Full Text
The Full Text of this article is available as a PDF (25.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Atzpodien J., Lopez Hänninen E., Kirchner H., Bodenstein H., Pfreundschuh M., Rebmann U., Metzner B., Illiger H. J., Jakse G., Niesel T. Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma. J Clin Oncol. 1995 Feb;13(2):497–501. doi: 10.1200/JCO.1995.13.2.497. [DOI] [PubMed] [Google Scholar]
- Facendola G., Locatelli M. C., Pizzocaro G., Piva L., Pegoraro C., Pallavicini E. B., Signaroldi A., Meregalli M., Lombardi F., Beretta G. D. Subcutaneous administration of interleukin 2 and interferon-alpha-2b in advanced renal cell carcinoma: a confirmatory study. Br J Cancer. 1995 Dec;72(6):1531–1535. doi: 10.1038/bjc.1995.542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gailani M. R., Bale S. J., Leffell D. J., DiGiovanna J. J., Peck G. L., Poliak S., Drum M. A., Pastakia B., McBride O. W., Kase R. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell. 1992 Apr 3;69(1):111–117. doi: 10.1016/0092-8674(92)90122-s. [DOI] [PubMed] [Google Scholar]
- Huland E., Huland H. Local continuous high dose interleukin 2: a new therapeutic model for the treatment of advanced bladder carcinoma. Cancer Res. 1989 Oct 1;49(19):5469–5474. [PubMed] [Google Scholar]
- Johnson R. L., Rothman A. L., Xie J., Goodrich L. V., Bare J. W., Bonifas J. M., Quinn A. G., Myers R. M., Cox D. R., Epstein E. H., Jr Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 1996 Jun 14;272(5268):1668–1671. doi: 10.1126/science.272.5268.1668. [DOI] [PubMed] [Google Scholar]
- Kimonis V. E., Goldstein A. M., Pastakia B., Yang M. L., Kase R., DiGiovanna J. J., Bale A. E., Bale S. J. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet. 1997 Mar 31;69(3):299–308. [PubMed] [Google Scholar]
- Milán T., Kaprio J., Verkasalo P. K., Jansén C. T., Teppo L., Koskenvuo M. Hereditary factors in basal cell carcinoma of the skin: a population-based cohort study in twins. Br J Cancer. 1998 Dec;78(11):1516–1520. doi: 10.1038/bjc.1998.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neale M. C., Eaves L. J., Kendler K. S. The power of the classical twin study to resolve variation in threshold traits. Behav Genet. 1994 May;24(3):239–258. doi: 10.1007/BF01067191. [DOI] [PubMed] [Google Scholar]
- Philip T., Negrier S., Lasset C., Coronel B., Bret M., Blay J. Y., Merrouche Y., Carrie C., Kaemmerlen P., Chauvin F. Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients. Br J Cancer. 1993 Nov;68(5):1036–1042. doi: 10.1038/bjc.1993.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steineck G., Strander H., Carbin B. E., Borgström E., Wallin L., Achtnich U., Arvidsson A., Söderlund V., Näslund I., Esposti P. L. Recombinant leukocyte interferon alpha-2a and medroxyprogesterone in advanced renal cell carcinoma. A randomized trial. Acta Oncol. 1990;29(2):155–162. doi: 10.3109/02841869009126537. [DOI] [PubMed] [Google Scholar]
- Wagstaff J., Baars J. W., Wolbink G. J., Hoekman K., Eerenberg-Belmer A. J., Hack C. E. Renal cell carcinoma and interleukin-2: a review. Eur J Cancer. 1995;31A(3):401–408. doi: 10.1016/0959-8049(94)00494-p. [DOI] [PubMed] [Google Scholar]